Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Fecha de publicación: November 2019

DOI: http://dx.doi.org/10.1136/annrheumdis-2018-214918

Autores: Daniel Aletaha, Jen-fue Maa, Su Chen, Sung-Hwan Park, Dave Nicholls, Stefan Florentinus, Daniel Furtner, Josef S Smolen.

Background: To determine if disease duration and number of prior disease-modifying antirheumatic drugs (DMARDs) affect response to therapy in patients with established rheumatoid arthritis (RA).